ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #3,958Top JournalHybrid

Biomaterials Advances

Acronym:msec
•
Abbreviation (ISO):MAT SCI ENG C-MATER
•
Identifier (ISSN):2772-9508(Print)
•
Publisher:Elsevier BV
Clarivate JCR Index Advisory: Active (SCIE)
Clarivate IF (2026)
6.7↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Biomaterials Advances

WoS Q1
047115.0820184.9620195.8820207.3320218.462022020235.52024620256.72026
Annual Impact Factor Metric
Current (2026):6.7
Scopus SJR & RankScopus Q1
1.138
#3,958

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
212

212 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
1,074articles/year
26.49% Gold OA•93.04% Original Research

Aims & Scope

Biomaterials Advances, previously known as Materials Science and Engineering: C-Materials for Biological Applications (P-ISSN: 0928-4931, E-ISSN: 1873-0191). Includes topics at the interface of the biomedical sciences and materials engineering. These topics include: • Bioinspired and biomimetic materials for medical applications • Materials of biological origin for medical applications • Materials for "active" medical applications • Self-assembling and self-healing materials for medical applications • "Smart" (i.e., stimulus-response) materials for medical applications • Ceramic, metallic, polymeric, and composite materials for medical applications • Materials for in vivo sensing • Materials for in vivo imaging • Materials for delivery of pharmacologic agents and vaccines • Novel approaches for characterizing and modeling materials for medical applications Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Materials Science and Engineering C. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources. Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Topics Covered (Recognized by AI)
Chemistry95.4%Biology92.4%Materials science84.8%Medicine84.6%Genetics82%Engineering78.8%Organic chemistry77%Biochemistry70.2%Physics58.6%Chemical engineering58.2%Nanotechnology54.8%Composite material46.4%Biomedical engineering46.2%Internal medicine45.4%Quantum mechanics36.6%Cell biology36%Surgery34.4%Metallurgy32.4%In vitro28%Nuclear magnetic resonance27%Immunology27%Geology24.4%Pathology24.2%Computer science23.8%Biotechnology21.8%In vivo21.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Q1
Rank14/58
IndexSCIE
JCISCIE2026

MATERIALS SCIENCE, BIOMATERIALS

Q2
Rank15/58
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
2026Latest
IF6.7
Articles / Year443
Total Citations338
2025
IF6
Articles / Year435
Total Citations2,040
2024
IF5.5
Articles / Year333
Total Citations4,149
2023
IF0
Articles / Year391
Total Citations7,052
2022
IF8.457
Articles / Year518
Total Citations12,811

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,958Scopus Q1SCImago Profile
Scopus Coverage:2022-2026
Scopus Broad Areas:Chemical EngineeringEngineeringMaterials Science
Scopus Citation Rank (SJR)Q1
1.138

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.85

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,441 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,181
3-Year Documents1,140
Citable Documents1,134

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BioengineeringQ1
BiomaterialsQ1
Biomedical EngineeringQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区MATERIALS SCIENCE, BIOMATERIALS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biomaterials Advances (acronym: msec, abbr: MAT SCI ENG C-MATER, ISSN: 2772-9508) is a peer-reviewed international scholarly journal in the field of Engineering & Technology, published by Elsevier BV in Netherlands since 1993. The periodical holds a Journal Impact Factor (JIF) of 6.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.138 (Q1), an H-index of 212.

The journal enforces rigorous peer evaluation with an average review speed of 7.2, a publication frequency of Monthly, an annual output of approximately 1,074 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,441 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier BV
Publication Language
English
Frequency
Monthly
Founding Year
1993
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7501d6e4-15d2-44d6-b265-09e6a610f3d8
Database Updated: 2026-10-16